Eliseo Salinas
Company: Delix Therapeutics
Job title: Head of Research & Development
Seminars:
Chair’s Opening Remarks 8:50 am
day: Conference Day Two
Panel Discussion: Reviewing the Current Therapeutic Landscape & Pipeline Advances in Neuropsychiatry 8:30 am
Evaluating the latest advancements in psychedelic and non-psychedelic therapeutic development Are the ‘mind altering’ effects of psychedelics necessary for therapeutic action? Exploring new potential treatment options for neuropsychiatric disordersRead more
day: Conference Day One
Chair’s Opening Remarks 8:20 am
day: Conference Day One